Exclusive Tail Fold Patent Granted to Switchblade Flying Car Manufacturer

New Patent Allows Flying Surfaces toRetract Into Body of Vehicle Sam Bousfield, CEO, Samson Sky, has been granted his eighth design patent from the U.S. Patent and Trademark Office and international patent offices for the Switchblade Flying Car. This newest patent was issued on November 19, 2025 and covers the unique tail fold and retraction […]

PRMB SHAREHOLDER NOTICE: Primo Brands Corporation (PRMB) Sued Amid Botched Integration, CEO Departure — Hagens Berman

A securities class action lawsuit has been filed against beverage company Primo Brands Corporation (NYSE: PRMB) in the wake of its troubled merger with BlueTriton Brands. https://mma.prnewswire.com/media/2590203/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg The suit seeks to represent investors who purchased or otherwise acquired the common stock of Primo Water between June 17, 2024 and November 8, 2024. The suit also

Stride (LRN) Securities Class Action Pending Over Enrollment Drop, Compliance Allegations — Hagens Berman

Stride, Inc. (NYSE: LRN), one of the nation's largest providers of online educational services, is now facing a securities class action lawsuit from shareholders after a series of disclosures revealed significant operational and compliance challenges, leading to a precipitous drop in its stock price. https://mma.prnewswire.com/media/2590203/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg Prominent shareholder rights law firm Hagens Berman is actively investigating

enVVeno Medical (NASDAQ:NVNO) to Participate in a Live Virtual Investor CEO Connect Segment

Moderated webcast with Robert Berman, Chief Executive Officer of enVVeno Medical on Wednesday, December 3rd at 4:00 PM ET IRVINE, CA / ACCESS Newswire / November 26, 2025 / enVVeno Medical Corporation (Nasdaq:NVNO) ("enVVeno Medical" or the "Company"), today announced that Robert Berman, Chief Executive Officer of enVVeno Medical will participate in a Live Virtual

Telix Pharmaceuticals (TLX) Hit with Investor Lawsuit Alleging Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability– Hagens Berman

TLX Investors with Losses Encouraged to Contact Hagens Berman Telix Pharmaceuticals Ltd. (NASDAQ: TLX), a commercial-stage biopharmaceutical company specializing in diagnostic and therapeutic radiopharmaceuticals, is now the target of a securities class action lawsuit following a series of regulatory setbacks and steep stock declines over the summer. https://mma.prnewswire.com/media/2590203/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg Hagens Berman is actively investigating the allegations

Inspire Medical (INSP) Faces Securities Class Action Over Claims It Misled Investors on Next-Generation Device Launch — Hagens Berman

Medical device manufacturer Inspire Medical Systems, Inc.(NYSE: INSP) is the subject of a securities class action lawsuit following a sharp decline in its stock price, with shareholders alleging the company misled investors about the launch of its latest product, the Inspire V device for obstructive sleep apnea. https://mma.prnewswire.com/media/2590203/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg Hagens Berman is investigating the allegations. The

CarMax, Inc. (KMX) Securities Class Action Filed, Shares Fall Again Amid Disclosure of Expected Comparable Store Unit Sales Decline — Hagens Berman

KMX Investors with Losses Encouraged to Contact Hagens Berman On November 6, 2025, investors inCarMax, Inc. (NYSE: KMX) saw shares plummet $9.93 (-24%) after the company announced that it fired CEO Bill Nash and issued its new Q3 2026 preliminary outlook on comparable store used unit sales, calling for a decline of 8%-12% from a

James Hardie Industries (JHX) Lawsuit Alleging Securities Fraud Over Inventory Misstatements Pending, CFO Replaced — Hagens Berman

JHX Investors with Losses Encouraged to Contact the Firm On November 17, 2025, James Hardie Industries plc (NYSE: JHX) announced the departure of its CFO (Rachel Wilson) who was immediately replaced by outsider Ryan Lada. https://mma.prnewswire.com/media/2590203/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg This development follows the 34% August 20, 2025 collapse in James Hardie's share price and the class-action lawsuit filed

MoonLake Immunotherapeutics’ (MLTX) Stock Crashes 90%, Triggers Lawsuit After Reported Phase 3 Trial Data for Sole Drug Candidate — Hagens Berman

MoonLake Immunotherapeutics (NASDAQ: MLTX), a clinical-stage biotechnology company, has been hit with a securities fraud class action lawsuit after its share price plummeted nearly 90% in a single day. The sharp decline was triggered by the release of disappointing Phase 3 trial results for its lead and only drug candidate, sonelokimab (SLK). https://mma.prnewswire.com/media/2590203/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg Global plaintiffs'

aTyr Pharma (ATYR) Securities Class Action Pending Over Key Drug’s Efficacy — Hagens Berman

ATYR Investors with Losses Encouraged to Contact the Firm The financial and legal pressures onaTyr Pharma, Inc. (NASDAQ: ATYR) intensified earlier this month as the clinical-stage biotech company reported third-quarter results on Nov. 6 that missed Wall Street estimates, all while navigating high-stakes securities class action litigation. https://mma.prnewswire.com/media/2590203/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg Global plaintiffs' rights firm Hagens Berman has

Scroll to Top